Dylan Cease's shoulder MRI came back with real relief attached to it.

Cease said the imaging revealed inflammation, but nothing that should require surgery or affect his 2027 season.

That's the best possible outcome for a pitcher who's carried this rotation through injury after injury all year.

Toronto and Cease are still deciding whether he'll pitch again in 2026, a decision that remains genuinely unresolved with the season nearly finished.

A return this season looks unlikely at this point, given the timeline left and the need to manage this properly rather than rush him back for a handful of games.

Why the long-term outlook matters more than these final games

Inflammation without structural damage is a significant distinction here. It suggests rest and management, rather than a procedure that would threaten next season.

For a Blue Jays team clinging to slim playoff odds with just a handful of games remaining, losing Cease for the stretch run is a real blow regardless of the encouraging long-term prognosis.

He's been the one true constant in this rotation all season, anchoring a staff that's absorbed injuries across nearly every other spot.

Protecting his 2027 outlook makes sense given how unlikely Toronto's playoff math already is. Risking further injury for a handful of low-probability games would be a bad trade for the organization long-term.

Whether he takes the mound again this season at all, even in a limited relief capacity if Toronto somehow reaches October, remains the open question.

For now, the news is mostly good. Cease avoids surgery, and his outlook heading into next season stays intact even if this year's final chapter closes without him.